• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

NIR to sell CMT digital products

Article

Israeli medical imaging developer CMT Medical Technologies has signed an agreement with National Imaging Resources of Birmingham, AL, for distribution of CMT’s SmartSpot digital radiography-fluoroscopy and digital angiography products. The deal

Israeli medical imaging developer CMT Medical Technologies has signed an agreement with National Imaging Resources of Birmingham, AL, for distribution of CMT’s SmartSpot digital radiography-fluoroscopy and digital angiography products. The deal should help Haifa-based CMT in its effort to expand its horizons beyond the OEM market, which has historically been a mainstay for the company.

CMT’s SmartSpot products use a 1K x 1K x 12-bit CCD camera and provide simultaneous acquisition, archiving, viewing, and filming of digital R/F and angio images. Data are saved to hard disk rather than in RAM storage, which increases the system’s speed and performance, according to Israel Hakalir, vice president and general manager. CMT introduced SmartSpot last year.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.